×
About 4,855 results

ALLMedicine™ Rabies Center

Research & Reviews  1,671 results

Efficacy of RTS,S/AS01E malaria vaccine administered according to different full, fract...
https://doi.org/10.1016/S1473-3099(22)00273-0
The Lancet. Infectious Diseases; Samuels AM, Ansong D et. al.

Jun 27th, 2022 - Controlled infection studies in malaria-naive adults suggest increased vaccine efficacy for fractional-dose versus full-dose regimens of RTS,S/AS01. We report first results of an ongoing trial assessing different fractional-dose regimens in childr...

Safety and immunogenicity of human rabies vaccine for the Chinese population after PEP:...
https://doi.org/10.1016/j.vaccine.2022.06.035
Vaccine Wang L, Zhang J et. al.

Jun 25th, 2022 - To evaluate the safety and immunogenicity of rabies vaccine for human use after post-exposure in China. A systematic search was performed from PubMed, EMBASE, CNKI and Cochrane Library database, supplemented by manual retrieval. According to the i...

Implementation of Clinical Decision Support on Emergency Department Delivery of Human R...
https://doi.org/10.1001/jamanetworkopen.2022.16631
JAMA Network Open; Yuan F, Iso T et. al.

Jun 22nd, 2022 - Fatal human rabies infections can be prevented through appropriate rabies postexposure prophylaxis (PEP). Errors in patient selection and administration of human rabies immune globulin in the emergency department (ED) setting were identified in a ...

Dosage-Escalation Study of the Safety and Immunogenicity of a Novel Rabies Vaccine ChAd155-RG vs. the Comparator RABAVERT Vaccine in Healthy Adult Subjects
https://clinicaltrials.gov/ct2/show/NCT04019444

Jun 21st, 2022 - This is a single-center, observer-blinded, Phase 1, dosage-escalation trial to evaluate the safety, tolerability, reactogenicity, and immunogenicity of ChAd155-RG compared with RABAVERT in rabies virus-naïve healthy male and non-pregnant female ad...

Immunogenicity of Rabies Vaccine for Pre Exposure Prophylaxis
https://clinicaltrials.gov/ct2/show/NCT02374814

Jun 13th, 2022 - This is an exploratory vaccine trial to evaluate immunogenicity of a non-licensed dosing schedule and route of administration for a currently FDA licensed rabies vaccine for pre-exposure prophylaxis against rabies infection. The goal of this study...

see more →

Guidelines  1 results

Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent huma...
https://doi.org/10.1016/j.annemergmed.2010.05.020
Annals of Emergency Medicine;

Jul 22nd, 2010 - Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies-recommendations of the Advisory Committee on Immunization Practice.|2010| ,|immunology,immunology,prevention & control,administration & dosage,adverse ...

see more →

Drugs  11 results see all →

Clinicaltrials.gov  117 results

Dosage-Escalation Study of the Safety and Immunogenicity of a Novel Rabies Vaccine ChAd155-RG vs. the Comparator RABAVERT Vaccine in Healthy Adult Subjects
https://clinicaltrials.gov/ct2/show/NCT04019444

Jun 21st, 2022 - This is a single-center, observer-blinded, Phase 1, dosage-escalation trial to evaluate the safety, tolerability, reactogenicity, and immunogenicity of ChAd155-RG compared with RABAVERT in rabies virus-naïve healthy male and non-pregnant female ad...

Immunogenicity of Rabies Vaccine for Pre Exposure Prophylaxis
https://clinicaltrials.gov/ct2/show/NCT02374814

Jun 13th, 2022 - This is an exploratory vaccine trial to evaluate immunogenicity of a non-licensed dosing schedule and route of administration for a currently FDA licensed rabies vaccine for pre-exposure prophylaxis against rabies infection. The goal of this study...

Study of Purified Vero Rabies Vaccine Compared With Two Reference Rabies Vaccines in a Simulated Post-Exposure Regimen in Adults
https://clinicaltrials.gov/ct2/show/NCT03965962

May 24th, 2022 - Study duration per participant was approximately 7 months including: 1 day of screening and vaccination, a total of 5 vaccine injections over a 28-day period, 1 safety-follow up visit at Day 42, 1 safety follow-up/end of study visit at Day 56 and ...

Survey of Human Rabies Immune Globulin Safety in Children
https://clinicaltrials.gov/ct2/show/NCT05382650

May 19th, 2022 - BACKGROUND: Rabies PEP consists of thorough wound cleansing, administration of HRIG 20 IU/kg body weight, and 4 to 5 doses of rabies vaccine. The safety of HRIG 300 IU/mL has been confirmed only for adult patients. Although the safety of HRIG 300 ...

Immunogenicity and Safety of a Purified Vero Rabies Vaccine- Serum Free (VRVg) Assessed With the Institut Pasteur du Cambodge (IPC: 2-2-2-0-0) and the Thai Red Cross (TRC: 2-2-2-0-2) Intradermal Re...
https://clinicaltrials.gov/ct2/show/NCT04478084

May 12th, 2022 - The duration of each participant's participation in the study is approximately 7 months (28 day-vaccination period followed by 6 month safety follow-up period).

see more →

News  136 results

GSK, Novartis Pledge Funds for Neglected Tropical Diseases
https://www.medscape.com/viewarticle/976095

Jun 24th, 2022 - LONDON (Reuters) - GSK and Novartis reinforced commitments on Thursday to tackle neglected tropical diseases, as world leaders and health experts gather in Rwanda to discuss ways to better combat illnesses affecting more than a billion people, mos...

Update on Rabies, TBE, and Cholera Vaccines Before Travel
https://www.medscape.com/viewarticle/974443

May 27th, 2022 - Healthcare providers should be aware of important updates to vaccine recommendations that could affect patients preparing to travel internationally this summer. This includes information about: New rabies pre-exposure prophylaxis guidelines (PrEP)...

Rabies: CDC Updates and Simplifies Preexposure Prophylaxis Vaccination Recommendations
https://www.medscape.com/viewarticle/974298

May 19th, 2022 - Each year, there are about 59,000 deaths from rabies globally. Most of these occur outside the United States and are the result of dog bites. Since infection with rabies is almost always fatal, there has been considerable attention given to vaccin...

Cats, toxoplasmosis, and psychosis: Understanding the risks
https://www.mdedge.com/psychiatry/article/254207/schizophrenia-other-psychotic-disorders/cats-toxoplasmosis-and-psychosis
E. Fuller Torrey, MD

May 2nd, 2022 - It has been clearly established that most human infectious diseases are caused by infectious agents that have been transmitted from animals to humans. 1 Based on published estimates from the 2000s, 60% to 76% of emerging infectious disease events a.

Run Into a Rabid Animal? What to Know
https://www.medscape.com/viewarticle/971878

Apr 11th, 2022 - News of rabid foxes or other animals doesn't make quite as much of a stir here in Western Maryland as it did on Capitol Hill. Here, it seems to be more regarded as a hazard of country living. https://twitter.com/thecapitolfox/status/15114073316612...

see more →

Patient Education  6 results see all →